Two thirds of Korean drugmakers struggle to cut promotion expenses in first quarter

Influenced by the government-mandated cuts in drug prices last year, Korean drug manufacturers are finding ways to stem predicted losses by slashing their promotion expenditures, according to data obtained by Yakup.com, a pharmaceutical information company.

The data revealed Sunday that the country's 53 listed pharmaceutical companies on average spent 33.6 percent of their revenue on marketi...